Drug Trial Radar · NCT05327114
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
201
Planned (sponsor's estimate)
Start
Sep 23, 2022
Primary completion
Dec 15, 2026
Study completion Jul 11, 2028
Sponsor
- Lead sponsor
- Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
- Sponsor type
- Industry
- First posted
- Apr 14, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main purpose of this study is to evaluate the safety and efficacy of nipocalimab compared to placebo in delaying relapse in adults with chronic inflammatory demyelinating polyneuropathy (CIDP) who initially respond to nipocalimab in Stage A.
Conditions
- Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Interventions
NipocalimabDrug
Nipocalimab will be administered intravenously.
PlaceboDrug
Placebo will be administered intravenously.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Stage B: Time to First Occurrence of a Relapse EventTime frame: Up to 52 weeks
Locations
120 sites in 19 countries. Site status is shown where the registry gives one.
IMMUNOe Health and Research Centers
Centennial, Colorado · Active not recruiting
Healthcare Innovations Institute Inc
Coral Springs, Florida · Completed
Neurology Associates PA
Maitland, Florida · Completed
ALS Center at the University of Miami
Miami, Florida · Active not recruiting
Augusta University
Augusta, Georgia · Completed
University of Kansas Medical Center
Kansas City, Kansas · Completed
Johns Hopkins Hospital
Baltimore, Maryland · Completed
Boston Clinical Trials
Boston, Massachusetts · Completed
Beaumont Hospital Royal Oak
Royal Oak, Michigan · Completed
Kansas City Veterans Affairs Medical Center
Kansas City, Missouri · Completed
The Neurological Institute of New York
New York, New York · Completed
South Shore Neurologic Associates - Patchogue
Patchogue, New York · Completed
The Neurological Institute, PA
Charlotte, North Carolina · Completed
Cleveland Clinic Main Campus
Cleveland, Ohio · Active not recruiting
Austin Neuromuscular Center
Austin, Texas · Completed
Advocate Health - Aurora St. Luke's Medical Center
Milwaukee, Wisconsin · Active not recruiting
Hospital Italiano de Buenos Aires
Buenos Aires, Argentina · Active not recruiting
Instituto Fleni
Buenos Aires, Argentina · Recruiting
Hospital Gral Agudos Ignacio Pirovano
Buenos Aires, Argentina · Completed
INECO Neurociencias Orono
Rosario, Argentina · Recruiting
The Alfred Hospital
Melbourne, Australia · Completed
Gold Coast University Hospital
Parkwood, Australia · Completed
The Ottawa Hospital Ottawa NeuroMuscular Centre
Ottawa, Canada · Recruiting
Peking University First Hospital
Beijing, China · Completed
Xuanwu Hospital ,Capital Medical University
Beijing, China · Active not recruiting
Beijing Tiantan Hospital, Capital Medical University
Beijing, China · Active not recruiting
Peking University Third Hospital
Beijing, China · Completed
The First Hospital of Jilin University
Changchun, China · Active not recruiting
The Third Xiangya Hospital of Central Sourth University
Changsha, China · Active not recruiting
Xiangya Hospital Central South University
Changsha, China · Completed
Sichuan Provincial Peoples Hospital
Chengdu, China · Completed
Chifeng Municipal Hospital
Chifeng, China · Completed
Fujian Medical University Union Hospital
Fuzhou, China · Active not recruiting
The First Affiliated Hospital Sun Yat sen University
Guangzhou, China · Active not recruiting
Qilu Hospital of Shandong University
Jinan, China · Active not recruiting
Qianfoshan hospital of Shandong Province
Jinan, China · Completed
The First Affiliated Hospital of NanChang University
Nanchang, China · Active not recruiting
Huashan Hospital Fudan University
Shanghai, China · Active not recruiting
Tong Ren Hospital Shanghai Jiao Tong University school of medicine
Shanghai, China · Completed
Renmin Hospital of Wuhan University
Wuhan, China · Completed
Showing 40 of 120 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.